New research suggests that starting antiretroviral therapy while the immune system is still relatively strong rather than at the later stages of HIV infection could be beneficial. Up to so far, guidelines on AIDS treatment require that ARV'€™s should be started when a person'€™s CD 4 cell-count reaches the clinically crucial 200 mark or less. Health-e News Service, reports.